Combined the finding that 83.5% of HGSOC in our study were satisfied/highly satisfied with having reflex BRCA1/2 tumour genetic testing completed as part of their cancer care, available data suggest gaps in knowledge about tumour genetic testing may be of minimal concern for cancer patients. The gene discussed is BRCA1; the disease is neoplasm.